Provision of Antioxidant Therapy in Hemodialysis (PATH)

Volume: 25, Issue: 3, Pages: 623 - 633
Published: Mar 1, 2014
Abstract
Increased markers of oxidative stress and acute-phase inflammation are prevalent in patients undergoing maintenance hemodialysis therapy (MHD), and are associated with increased mortality and hospitalization rates and decreased erythropoietin responsiveness. No adequately powered studies have examined the efficacy of antioxidant therapies on markers of inflammation and oxidative stress. We tested the hypothesis that oral antioxidant therapy over...
Paper Details
Title
Provision of Antioxidant Therapy in Hemodialysis (PATH)
Published Date
Mar 1, 2014
Volume
25
Issue
3
Pages
623 - 633
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.